U.s. NeuroSurgical

(OTC) USNU

Current PriceN/A

Market CapN/A

Since IPO (1999)+1,660%

5 Year+176%

1 Year+59%

1 Month-13%

U.s. NeuroSurgical Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.02M

Net Income (TTM)

$7.80M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

USNU News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About U.s. NeuroSurgical

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

CEO

Prasad A. Jeereddi, MD

Website

www.usneurosurgical.com

Headquarters

Ontario, MD 20850, US

USNU Financials

Key Financial Metrics (TTM)

Gross Margin

12%

Operating Margin

-4%

Net Income Margin

-8%

Return on Equity

-2%

Return on Capital

-72%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$118.00K

Operating Income

$3.84M

EBITDA

$3.84M

Operating Cash Flow

$2.94M

Capital Expenditure

$0.00

Free Cash Flow

$2.94M

Cash & ST Invst.

$3.76M

Total Debt

$38.00K

U.s. NeuroSurgical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.02M

+28.6%

Gross Profit

$127.00K

-68.1%

Gross Margin

12.40%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$5.78M

-465.9%

EBITDA

$1.83M

-270.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$3.72M

-6.1%

Accounts Receivable

$330.00K

+74.6%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$38.00K

+11.8%

Return on Assets

-1.17%

N/A

Return on Invested Capital

-72.11%

N/A

Free Cash Flow

$2.02M

-282.9%

Operating Cash Flow

$1.49M

-183.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PCHMPharmChem, Inc.

PCHMPharmChem, Inc.$3.75+0.27%

HQDAHQDA Elderly Life Network Corp.

HQDAHQDA Elderly Life Network Corp.$0.13+2.84%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

FFord Motor Company

FFord Motor Company$11.88-0.02%

Questions About USNU

What is the current price of U.s. NeuroSurgical?

U.s. NeuroSurgical is trading at N/A per share.

What is the 52-week range for U.s. NeuroSurgical?

Over the past 52 weeks, U.s. NeuroSurgical has traded between N/A and N/A.

How much debt does U.s. NeuroSurgical have?

As of the most recent reporting period, U.s. NeuroSurgical reported total debt of $38,000.

How much cash does U.s. NeuroSurgical have on hand?

U.s. NeuroSurgical reported $3.76M in cash and cash equivalents in its most recent financial results.

What is U.s. NeuroSurgical’s dividend yield?

U.s. NeuroSurgical does not currently have a dividend yield.

U.s. NeuroSurgical

U.s. NeuroSurgical Financials at a Glance

USNU News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About U.s. NeuroSurgical

USNU Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

U.s. NeuroSurgical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About USNU

What is the current price of U.s. NeuroSurgical?

What is the 52-week range for U.s. NeuroSurgical?

How much debt does U.s. NeuroSurgical have?

How much cash does U.s. NeuroSurgical have on hand?

What is U.s. NeuroSurgical’s dividend yield?

Premium Investing Services